Related Experiment Video
Updated: Jun 4, 2025
06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
184
Progressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium
James P Bridges1,2, Eszter K Vladar2, Jonathan S Kurche2,3
1Department of Medicine, National Jewish Health, Denver, Colorado, USA.
The Journal of Clinical Investigation
|January 2, 2025
Summary
Idiopathic pulmonary fibrosis (IPF) develops from a two-hit process: initial epithelial vulnerability followed by injury that reprograms cells. Understanding these stages offers new therapeutic targets for curative treatments.
Area of Science:
- Pulmonology
- Pathology
- Genetics
Background:
- Idiopathic pulmonary fibrosis (IPF) is a complex lung disease with known genetic and environmental causes.
- Current understanding suggests a multi-step process leading to fibrosis.
Purpose of the Study:
- To propose a "two-hit" conceptual model for IPF development.
- To contextualize IPF etiology and progression temporally.
- To identify novel therapeutic targets for IPF.
Main Methods:
- Review of existing literature on IPF pathogenesis.
- Conceptual synthesis of genetic and environmental factors.
- Analysis of cellular and tissue remodeling mechanisms in IPF.
Main Results:
- IPF development requires an initial "hit" causing epithelial vulnerability.
- A second "hit" triggers reprogramming of distal epithelia, initiating a profibrotic phenotype.
- Disease progression involves stages of vulnerability, early disease, and persistent fibrosis.
Conclusions:
- A "two-hit" model provides a framework for understanding IPF etiology and progression.
- Identifying specific drivers at each stage can lead to targeted therapies.
- This approach may shift IPF treatment from palliative to curative.
More Related Videos
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:23Cystic Fibrosis: Pathogenesis
185
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
185